Use of a gracilis muscle flap to facilitate delayed ileal pouch-anal anastomosis

2000 ◽  
Vol 43 (11) ◽  
pp. 1628-1631 ◽  
Author(s):  
Robert C. Shamberger ◽  
Charles A. Hergrueter ◽  
Craig W. Lillehei
2009 ◽  
Vol 2009 ◽  
pp. 1-4 ◽  
Author(s):  
Feride Aydin ◽  
Claus Ferdinand Eisenberger ◽  
Andreas Raffel ◽  
Alexander Rehders ◽  
Stefan Benedikt Hosch ◽  
...  

Fistulae between an ileal pouch and the vagina are an uncommon complication of ileal pouch-anal anastomosis following proctocolectomy and mucosectomy in patients with familial adenomatous polyposis coli. Several reports describe the successful use of muscle flaps to close recurrent pouch-vaginal-fistulae (PVF). However, series only contain small numbers and an optimal management has not yet been determined. We report the case of a 26-year old woman with a third recurrence of a PVF after proctocolectomy for treatment of familial adenomatous polyposis in October 2005. Because local approaches failed, definitive closure of the fistula was achieved by interposition of a gracilis muscle flap between the pouch-anal anastomosis and the vagina. The postoperative course was uneventful; the patient was discharged 7 days after surgery and remained free of recurrence and symptomatic complaints for 22 months now. The gracilis muscle flap proved to be an effective method in the treatment of recurrent PVF.


Author(s):  
Mohamed A. Abd El Aziz ◽  
Giacomo Calini ◽  
Fabian Grass ◽  
Kevin T. Behm ◽  
Anne-Lise D’ Angelo ◽  
...  

Author(s):  
Jonathan Pastrana Del Valle ◽  
Grace C. Lee ◽  
Jose Cataneo Serrato ◽  
Joseph D. Feuerstein ◽  
Liliana Grigorievna Bordeianou ◽  
...  

2021 ◽  
Vol 14 ◽  
pp. 175628482110233
Author(s):  
Wendy Rabbenou ◽  
Shannon Chang

Pouchitis is the most common complication in patients who have undergone restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA). Up to 81% of IPAA patients experience pouchitis, with 40% of patients presenting within the first year of surgery. Common risk factors include genetic mutations, extensive colitis, rheumatologic disorders, and primary sclerosing cholangitis. Currently, there are no medications with approved indications for pouchitis. As such, the conventional treatment of pouchitis is entirely off-label. This paper is intended to be a practical and up-to-date review of available therapies used for the management of pouchitis. The mainstay of treatment for acute pouchitis remains antibiotics, but newer therapeutics have also shown promise in the treatment of chronic pouchitis. Common lifestyle considerations that may play a role in pouchitis are also reviewed. Plain language summary Medical treatment of pouchitis: a guide for the clinician The ileal pouch-anal anastomosis (“pouch”) is the most common way patients who require surgery to remove their colon are able to avoid a permanent ileostomy (“ostomy”). This pouch, created from the small intestines, serves as a reservoir to hold stool. The most common complication after pouch surgery is pouchitis. Pouchitis symptoms include more frequent bowel movements, urgency to defecate, blood in the stool, incontinence, and abdominal pain. This paper is intended to be a practical review of available therapies including medications and lifestyle changes that can be considered for the management of acute pouchitis, chronic pouchitis, and cuffitis.


Sign in / Sign up

Export Citation Format

Share Document